IDiyas

For the Inventor, By the Inventor

Littleton, MA, United States of America

Amorsa Therapeutics, Inc.


USPTO Granted Patents = 7



Forward Citations = 29

Loading Chart...
Loading Chart...

2 inventors (with patents filed for the assignee):

goldMedal Alex Nivorozhkin (7 out of 28 patents)

silverMedal Nelson Landrau (7 out of 20 patents)


7 patents:

1. 11613515 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2023-03-28),
2. 11603348 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2023-03-14),
3. 11554100 - Single-layer oral dose of neuro-attenuating ketamine (2023-01-17),
4. 10981859 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2021-04-20),
5. 10653629 - Single layer oral dose of neuro-attenuating ketamine (2020-05-19),
6. 10252982 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2019-04-09),
7. 9913803 - Single-layer oral dose of neuro-attenuating ketamine (2018-03-13),
Amorsa Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for neurological disorders. Our mission is to harness the power of neuroplasticity to create novel treatments that improve the lives of patients. With a strong pipeline of drug candidates targeting various neurological conditions, we are committed to advancing the field of neurology and bringing hope to those in need.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#7 in Littleton, MA

#2,240 in Massachusetts

#38,762 in US

...
Littleton, MA, United States of America

Amorsa Therapeutics, Inc.

Forward Citations = 29

2 inventors:

goldMedal Alex Nivorozhkin (7 out of 28 patents)

silverMedal Nelson Landrau (7 out of 20 patents)

Please report any incorrect information to support@idiyas.com
Loading…